Saracatinib inhibits necroptosis and ameliorates psoriatic inflammation by targeting MLKL

Jingyi Li(Fujian Medical University), Lisheng Li(Fujian Medical University)
Cell Death and Disease
February 8, 2024
10.1038/s41419-024-06514-y
Cited by 24

Related Papers

Repurposing of Ibrutinib and Quizartinib as potent inhibitors of necroptosis
|Communications Biology|2023|17
TWEAK Enhances E-selectin and ICAM-1 Expression, and May Contribute to the Development of Cutaneous Vasculitis
|PLoS ONE|2013|16